This case study explores the opportunities and challenges of the digital transformation journey of French wine and spirits company Pernod Ricard. As part of the transformation, the company launched four key digital programs (KDPs) aimed at using data and artificial intelligence to automate processes and drive data-driven decision-making. The case primarily focused on two of these: D-STAR, a sales recommendation system, and Matrix, a tool that optimized the allocation of advertising spend across brands. The company's future direction with the KDPs depended on addressing resistance, providing effective training and support, aligning with strategic goals, and overcoming logistical and data-related hurdles. The company needed to find a way to expand the KDPs further into new markets while reinforcing adoption where the KDPs had already been launched, and the decisions made would shape the path forward.
This case study explores the growth journey of Polish computer vision sports start-up ReSpo.Vision in an emerging entrepreneurial ecosystem. By providing 3D data and analysis to soccer clubs, ReSpo.Vision achieved significant milestones with a €1 million seed round, an EU innovation grant, and gained traction with top European soccer clubs. However, pressure to accelerate revenue growth led the company to consider a strategic shift towards immersive 3D visualizations for media and entertainment. Ahead of the upcoming funding round in early 2024, CEO Pawel Osterreicher faced a critical decision between scaling the existing business or creating a new business line. The case study highlights the opportunities and challenges associated with this shift in the context of a new and emerging market.
The case study examines the journey toward value-based healthcare at Karolinska University Hospital. The hospital's ambitious shift to a patient-centered care delivery model, accompanied by the construction of a new facility, encountered challenges such as high costs, staff dissatisfaction, and growing waiting lists. The departure of CEO Melvin Samsom in 2018 left the new director Bjorn Zoega with a budget deficit, discontented staff, and an outdated IT system. By 2023, however, Zoega had achieved a remarkable turnaround. Ranked among the top 6 international hospitals, the institution boasted a positive budget and had exceeded production assignments for three consecutive years. In 2023, Zoega pondered if his changes were long-lasting and how the Hospital should face new challenges such as an aging population and a shortage of qualified nurses.